Stonegate Capital Sets New Price Target for AB Science

Analysis firm Stonegate Capital has revised its price target for AB Science based on recent developments.

Published 6sem1 source

≈ 19sSpeed

The fact

This update reflects a reassessment of prospects for the French biopharmaceutical group.

Investors following analyst recommendations should note this change in positioning.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on June 9, 2026